GOLDLINE PHARMACEUTICAL LIMITE Share Price

GOLDLINE PHARMACEUTICAL LIMITE Share Price

BSE: 544759
|
Pharmaceuticals

₹ 33.00

+0.00 (0.00%)
1D
Last updated 07 Oct, 2026, 15:07 IST
--
0.00% up today
--
1D LOW
1D HIGH

GOLDLINE PHARMACEUTICAL LIMITE Returns Calculator

Volume
--
Average traded price
--
Last traded time
03:07:31 07 Oct
Last traded quantity
3,000
Circuit
L
H
₹26.40
₹39.60
52-week
L
H
₹28.50
₹60.00
Mkt Cap Cr
31.68
P/E
0.0
P/B
0.0
ROA
16.84%
ROE
39.26%
ROCE
29.32%
Quick Ratio
1.64
EV/EBITDA
0.0
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Goldline Pharmaceutical has not beaten FD return of 7%
Step 3 of 5
Valuation
Fairly Valued
Goldline Pharmaceutical appears to be fairly valued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,27,861.4135.315.1211.19%13.74%17.33%2.3121.97
Divis Laboratories2,54,318.9086.9515.1714.6%15.32%19.56%3.557.56
Torrent Pharmaceuticals1,79,153.2683.121.34.87%25.49%13.85%0.7538.98
Zydus Lifesciences1,15,710.4425.074.258.57%18.59%17.35%0.9115.38
Laurus Labs1,10,980.13101.8320.9510.38%16.77%16.14%0.6854.21
Cipla1,08,497.0232.013.127.92%11.27%14.95%2.518.37
Mankind Pharma1,02,649.9749.846.327.36%11.74%13.13%0.7427.05
Dr. Reddy's Laboratories1,00,361.9631.532.645.48%11.07%12.54%1.3516.0
Aurobindo Pharma96,951.1826.132.566.34%9.25%11.76%1.1512.47
Lupin91,782.6716.534.0914.47%23.76%24.88%1.429.92

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About GOLDLINE PHARMACEUTICAL LIMITE

GOLDLINE PHARMACEUTICAL LIMITE Share Price
ISIN
INE1CLW01015
Sector Market Cap
₹ 31.68 Cr

GOLDLINE PHARMACEUTICAL LIMITE Financial Highlights

  • Revenue: GOLDLINE PHARMACEUTICAL LIMITE reported revenue of ₹31.20 crore in FY26 vs ₹28.06 crore in FY25. It showed an increase of 11.19% on a yearly basis.
  • Operating Profit: GOLDLINE PHARMACEUTICAL LIMITE reported an operating profit of ₹5.39 crore in FY26 vs ₹3.86 crore in FY25. It showed an increase of 39.64% on a year-on-year basis.
  • Net Profit: GOLDLINE PHARMACEUTICAL LIMITE reported a net profit of ₹4.12 crore in FY26 vs ₹2.83 crore in FY25. It showed an increase of 45.58% on a yearly basis.
Know more
Promoters
57.29%
FII
5.16%
Other DII
7.81%
Retail and other
29.74%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
May 20265.16%
1 day
--
1 week
--
1 month
--
1 year
--
3 years
--
5 years
--
Day
Open / Close
Change %
07 Oct 26
₹32.02 / ₹33.00
-2.83%
06 Oct 26
₹29.25 / ₹33.96
+9.65%
01 Oct 26
₹31.70 / ₹30.97
-2.30%
30 Sep 26
₹28.56 / ₹31.70
+7.71%
Show more

GOLDLINE PHARMACEUTICAL LIMITE Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹31.20₹28.06₹23.57₹19.85
Other Income₹0.00₹0.00₹0.00₹0.00
Total Revenue₹31.20₹28.06₹23.57₹19.85
Total Expenses₹25.81₹24.20₹21.04₹19.45
Profit Before Tax₹5.39₹3.86₹2.53₹0.40
Tax₹1.27₹1.02₹0.72₹0.14
Profit After Tax₹4.12₹2.83₹1.81₹0.26
EPS - Basic₹5.97₹4.11₹3.01₹0.43
EPS - Diluted₹5.97₹4.11₹3.01₹0.43

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹5.39₹3.86₹2.53₹0.40
Income before WC changes₹6.94₹5.92₹4.35₹2.40
Change in Assets-₹3.41-₹2.56-₹1.91-₹0.52
Change in Liabilities₹0.26₹0.73₹0.69₹0.55
Change in WC-₹3.15-₹1.83-₹1.23₹0.03
Cash flow from Operations₹2.81₹3.18₹2.92₹2.39
Cash flow from Investing-₹0.06₹0.16-₹1.11-₹1.03
Cash flow from Financing-₹3.40-₹2.89-₹1.08-₹1.44
Total Cash Flow-₹0.65₹0.45₹0.74-₹0.09
Cash (Start of the year)₹1.24₹0.79₹0.05₹0.14
Cash (End of the year)₹0.59₹1.24₹0.79₹0.05

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹2.82₹2.93₹3.43₹2.57
Current Assets₹26.05₹23.35₹19.50₹16.82
Total Assets₹28.87₹26.28₹22.93₹19.39
Current Liabilities₹12.11₹11.77₹10.17₹9.00
Net Current Asset₹13.93₹11.58₹9.33₹7.83
Non-Current Liabilities₹2.51₹4.16₹4.90₹4.50
Equity Capital₹14.25₹10.35₹7.87₹5.89
Total Equity & Liabilities₹28.87₹26.28₹22.93₹19.39
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
33
3000
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 3000
Buy orders: 0%
Sell orders: 100%
Bearish
3
Neutral
5
Bullish
0
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
42.15
Neutral
ATR (14)
2.05
Neutral
STOCH(9,6)
75.38
Neutral
STOCH RSI (14)
88.46
Bearish
ADX(9)
38.12
Bearish
UO(9)
55.62
Neutral
ROC(12)
-9.84
Bearish
WillR(14)
-44.44
Neutral
Period
Simple value
Exponential vaue
5D
31.81
32.52
10D
32.17
32.84
20D
34.65
34.32
50D
37.92
37.08
100D
40.9
0
Volume trend — traded volume by day
7 Oct0L
6 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
GOLDLINE PHARMACEUTICAL LIMITE Share Price
GOLDLINE PHARMACEUTICAL LIMITE
Pharmaceuticals
Add Stock
Add Another

GOLDLINE PHARMACEUTICAL LIMITE Share Price FAQs

Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.